Epigenomics: Heino von Prondzynski
Jan 27, 2023
Epigenomics said this week that Heino von Prondzynski, chairman of the supervisory board, will resign from his position and the board effective March 31, 2023, for health reasons. Prondzynski was a member of the board from May 2007 to March 2010, and has been chairman since May 2012. Prior to that he served in numerous roles internationally, including as CEO of Roche Diagnostics and a member of Roche's corporate executive committee.